Brainstorm Cell Therapeutics Inc.
BCLI
Revenue
0.00
0.000.00%
-Assets
5.68M
▲2.34M▲69.74%
3 Months ChangeLiabilities
9.21M
▲312.00k▲3.51%
3 Months ChangeFree Cash Flow
-6.43M
▼-1.78M▼-38.27%
9 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-30
Form 8-K
ID: 0001104659-24-112442
2024-10-01
Form 8-K
ID: 0001104659-24-104920
2024-10-01
Form 8-K
ID: 0001104659-24-104667
2024-09-26
Form 8-K
ID: 0001104659-24-103157
2024-09-16
Form 8-K
ID: 0001104659-24-100239
2024-08-14
Form 10-Q
ID: 0001410578-24-001400
2024-08-14
Form 8-K
ID: 0001104659-24-089295
2024-07-30
Form 8-K
ID: 0001104659-24-083959
2024-07-19
Form 8-K
ID: 0001104659-24-081162
2024-06-28
Form 8-K
ID: 0001104659-24-075995